Reposted
Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
May 13, 2025 at 1:57 PM
Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Reposted
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41050133/
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41050133/
October 6, 2025 at 5:10 PM
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41050133/
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41050133/
Reposted
📣 𝗡𝗘𝗪 𝗧𝗢𝗢𝗟𝗞𝗜𝗧 𝗥𝗘𝗦𝗢𝗨𝗥𝗖𝗘: Get at-a-glance guidance on #ADPKD with our latest infographic, now part of the ISN Rare Kidney Diseases Toolkit! 🔗 http://lite.spr.ly/6...
July 17, 2025 at 11:01 AM
📣 𝗡𝗘𝗪 𝗧𝗢𝗢𝗟𝗞𝗜𝗧 𝗥𝗘𝗦𝗢𝗨𝗥𝗖𝗘: Get at-a-glance guidance on #ADPKD with our latest infographic, now part of the ISN Rare Kidney Diseases Toolkit! 🔗 http://lite.spr.ly/6...